Skip to content

Correlation of Dhatugata Amagati with Hematological Findings in Patients with Amavata (Rheumatoid Arthritis)

An Analytical Study to Evaluate the Association between Dhatugata Amagati and Rakta Pariksha (Blood Examination) in Amavata WSR to Rheumatoid Arthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100061
Enrollment
50
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Amavata (According to Signs and Symptoms) as well as Diagnosed cases of Rheumatoid Arthritis

Exclusion criteria

Exclusion criteria: Patients with chronic diseases such as (Malignancy, CKD, T1DM, Primary HTN, Heart diseases.), Pregnant and lactating mothers, Patients who are undergoing treatments for any other diseases, Patients with acute infections within the past 4 weeks Patients who have undergone major surgery within the past 3 months, Patients with severe psychiatric disorders, Patients with a history of alcohol or drug abuse, Patients unwilling to adhere to the study protocol

Design outcomes

Primary

MeasureTime frame
Correlation coefficient (r) between Dhatugata Ama severity and blood examination parameters (Ayurveda and modern aspects)Timepoint: At the end of the study

Secondary

MeasureTime frame
Identification of Dhatu-specific hematological markers for AmavataTimepoint: At the end of the study

Countries

India

Contacts

Public ContactHSV Jayasuriya

National Institute of Ayurveda, Jaipur

ssurendra452@gmail.com9414361874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026